Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 34

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

610

HTML

6107

Figures (1-6)

214

Tables (1-1)

168

Sum=7099

Publishing Process of This Article

Item

Count

Browse

1083

Download

859

Sum=1942

Sep 14, 2013 (publication date) through Jul 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 14, 2013; 19(34): 5706-5712
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5706

Full Size Figure Download Figure

Figure 4 Reduction ratio of the endoscopic submucosal dissection-induced ulcers in both groups. PPI: Proton-pump inhibitor; RM: Rebamipide.

Citation: Takayama M, Matsui S, Kawasaki M, Asakuma Y, Sakurai T, Kashida H, Kudo M. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. World J Gastroenterol 2013; 19(34): 5706-5712
URL: https://www.wjgnet.com/1007-9327/full/v19/i34/5706.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i34.5706